Newsletter

Blue Bird Announces Share Repurchase Program

Blue Bird Corporation (BLBD) announced on June 13 that the company’s Board of Directors authorized a new share repurchase program. The company’s previous $50 million share repurchase program closed in March 2018. Under the new program, the company can repurchase up to $25 million in outstanding common stock or series A convertible preferred stock over […]

Read more...

Ironwood Pharmaceuticals Receives FDA Orphan Drug Designation for Olinciguat

Ironwood Pharmaceuticals Inc. (IRWD) announced on June 7 that the FDA granted Orphan Drug Designation to Olinciguat (IW-1701) for patients with sickle cell disease.  The FDA grants orphan status to drugs that are intended to treat rare disorders that affect fewer than 200,000 patients in the United States. The designation gives the developer fee waivers […]

Read more...

Sabre Announces Repurchase in Secondary Stock Offering By Shareholders

On June 5, Sabre Corporation announced that two existing shareholders, TPG Global and Silver Lake Management Company, would be selling 16,000,000 of the company’s common shares in a secondary offering. As part of the agreement, Sabre will repurchase 1,000,000 of those 16,000,000 shares directly from the underwriter. Sabre expects to fund the purchase from its […]

Read more...

May 2018 Scorecard

The May 2018 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...